Home › Compare › MDBIF vs O

MDBIF vs O: Dividend Comparison 2026

MDBIF yields 80000.00% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDBIF wins by $5.2077213163602945e+25M in total portfolio value
10 years
MDBIF
MDBIF
● Live price
80000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.2077213163602945e+25M
Annual income
$51,949,472,569,259,090,000,000,000,000,000.00
Full MDBIF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — MDBIF vs O

📍 MDBIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDBIFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDBIF + O cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MDBIF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDBIF
Annual income on $10K today (after 15% tax)
$6,800,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,157,051,683,870,220,000,000,000,000,000.00/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, MDBIF beats the other by $44,157,051,683,870,220,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDBIF + O for your $10,000?

MDBIF: 50%O: 50%
100% O50/50100% MDBIF
Portfolio after 10yr
$2.6038606581801473e+25M
Annual income
$25,974,736,284,629,546,000,000,000,000,000.00/yr
Blended yield
99.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

MDBIF
No analyst data
Altman Z
-4.5
Piotroski
4/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDBIF buys
0
O buys
0
No recent congressional trades found for MDBIF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDBIFO
Forward yield80000.00% ✓5.28%
Annual dividend / share$2.00$3.23 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1% ✓
Portfolio after 10y$5.2077213163602945e+25M$34.2K ✓
Annual income after 10y$51,949,472,569,259,090,000,000,000,000,000.00 ✓$5,102.74
Total dividends collected$5.206883835920424e+25M$20.7K ✓
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: MDBIF vs O ($10,000, DRIP)

YearMDBIF PortfolioMDBIF Income/yrO PortfolioO Income/yrGap
1← crossover$8,010,700$8,000,000.00$10,818$608.16+$8.00M → MDBIF
2$5,997,879,860$5,989,308,411.21$11,787$741.68+$5997.87M → MDBIF
3$4,197,442,177,404$4,191,024,445,953.32$12,946$911.00+$4197442.16M → MDBIF
4$2,745,581,773,359,261$2,741,090,510,229,439.00$14,345$1,127.94+$2745581773.34M → MDBIF
5$1,678,610,723,842,080,800$1,675,672,951,344,586,500.00$16,056$1,409.05+$1678610723842.06M → MDBIF
6$959,257,110,940,495,000,000$957,460,997,465,984,000,000.00$18,171$1,777.83+$959257110940495.00M → MDBIF
7$512,381,218,321,420,100,000,000$511,354,813,212,713,760,000,000.00$20,820$2,268.21+$512381218321420096.00M → MDBIF
8$255,816,465,068,545,120,000,000,000$255,268,217,164,941,240,000,000,000.00$24,188$2,929.90+$255816465068545114112.00M → MDBIF
9$119,383,733,031,653,200,000,000,000,000$119,110,009,414,029,840,000,000,000,000.00$28,533$3,837.11+$1.193837330316532e+23M → MDBIF
10$52,077,213,163,602,950,000,000,000,000,000$51,949,472,569,259,090,000,000,000,000,000.00$34,235$5,102.74+$5.2077213163602945e+25M → MDBIF

MDBIF vs O: Complete Analysis 2026

MDBIF — Stock

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

Full MDBIF Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this MDBIF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDBIF vs SCHDMDBIF vs JEPIMDBIF vs KOMDBIF vs MAINMDBIF vs STAGMDBIF vs ADCMDBIF vs NNNMDBIF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.